Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Vile

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neckK J Harrington, C Lewanski, A D Northcote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft modelK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.
Human Gene Therapy|December 31, 1997
A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma modelS A Castleden, H Chong, I Garcia-Ribas, et al.
Cancer Research|April 5, 2000
Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growthA Bateman, F Bullough, S Murphy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2001
The effect of irradiation on the biodistribution of radiolabeled pegylated liposomesK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.
Gene Therapy|April 20, 2007
Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cellsL Sanchez-Perez, M Gough, J Qiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancerK J Harrington, C R Lewanski, A D Northcote, et al.
British Journal of Cancer|June 17, 2004
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft modelK J Harrington, K N Syrigos, P S Uster, et al.
Cancer Research|October 5, 2001
Macrophages orchestrate the immune response to tumor cell deathM J Gough, A A Melcher, A Ahmed, et al.
Gene Therapy|December 15, 2007
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivoC L White, T Menghistu, K R Twigger, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neckK J Harrington, C Lewanski, A D Northcote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft modelK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.
Human Gene Therapy|December 31, 1997
A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma modelS A Castleden, H Chong, I Garcia-Ribas, et al.
Cancer Research|April 5, 2000
Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growthA Bateman, F Bullough, S Murphy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2001
The effect of irradiation on the biodistribution of radiolabeled pegylated liposomesK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.
Gene Therapy|April 20, 2007
Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cellsL Sanchez-Perez, M Gough, J Qiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancerK J Harrington, C R Lewanski, A D Northcote, et al.
British Journal of Cancer|June 17, 2004
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft modelK J Harrington, K N Syrigos, P S Uster, et al.
Cancer Research|October 5, 2001
Macrophages orchestrate the immune response to tumor cell deathM J Gough, A A Melcher, A Ahmed, et al.
Gene Therapy|December 15, 2007
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivoC L White, T Menghistu, K R Twigger, et al.
Pageof 9